The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and effectiveness of radium-223 dichloride (Ra-223) in patients with mCRPC in real-world setting: A Japanese post-marketing study (PMS).
 
Shunji Takahashi
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Hakko Kirin; MSD; Nihonkayaku; Novartis; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo; Novartis
 
Yoshiyuki Kakehi
Consulting or Advisory Role - Bayer Yakuhin
Travel, Accommodations, Expenses - Takeda
 
Naoya Masumori
Honoraria - Astellas Pharma; Bayer Yakuhin; Janssen
 
Makoto Hosono
Honoraria - Bayer Yakuhin
 
Seigo Kinuya
Honoraria - Bayer Yakuhin
 
Yutaka Okayama
Employment - Bayer Yakuhin
 
Toshiyuki Sunaya
Employment - Bayer Yakuhin
 
Masafumi Okumura
Employment - Bayer Yakuhin
 
Hirotsugu Uemura
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb Japan; MSD; Ono Yakuhin; Pfizer
Research Funding - Astellas Pharma; AstraZeneca; Bayer Yakuhin; BrightPath Biotheraputics; Chugai Pharma; Covance; Daiichi Sankyo; EPS Corporation; ICON Clinical Research; IQVIA; Janssen; Mebix; Mediscience Planning; MSD; Ono Yakuhin; Osaka Urology Research Foundation; PAREXEL; Pfizer; Shin-nippon; Taiho Pharmaceutical; Takeda
Other Relationship - Asahi Kasei; Astellas Pharma; Daiichi Sankyo; Kissei Pharmaceutical; Novartis; Ono Yakuhin; Pfizer; Sanofi; Takeda